Van Hulzen Asset Management, LLC Supernus Pharmaceuticals, Inc. Transaction History
Van Hulzen Asset Management, LLC
- $1.32 Billion
- Q4 2024
A detailed history of Van Hulzen Asset Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 31 shares of SUPN stock, worth $1,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31Holding current value
$1,198% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding SUPN
# of Institutions
296Shares Held
61.1MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$402 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$238 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$197 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$111 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$102 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.07B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...